Skip to main content
. 2023 Aug 1;94(3):993–1004. doi: 10.3233/JAD-230004

Table 1.

Demographics of study participants

CATEGORY COUNT (% of sample)
Age (at enrollment):
  45–49 2 (8.7%)
  50–59 1 (4.4%)
  60–69 7 (30.4%)
  70–79 10 (43.5%)
  80–89 3 (13.0%)
Gender:
  Female 17 (73.9%)
  Male 6 (26.1%)
Ethnicity:
  Black, not of Hispanic origin 3 (13.0%)
  White, not of Hispanic origin 18 (78.3%)
  Hispanic 1 (4.4%)
  Other, Filipino 1 (4.4%)
Education Level:
  High school/GED 2 (8.7%)
  Associate degree/some college 2 (8.7%)
  Bachelor’s degree 7 (30.4%)
  Master’s or Doctorate degree 10 (43.5%)
  Other 2 (8.7%)
APOE Alleles:
  2/3 3 (13.0%)
  3/3 8 (34.7%)
  3/4 9 (39.1%)
  4/4 3 (13.0%)
Family history of Alzheimer’s Disease:
  Yes 11 (47.8%)
  No 11 (47.8%)
  Unknown 1 (4.4%)
Family history of another kind of dementia:
  Yes 7 (30.4%)
  No 16 (69.6%)
Diabetes:
  Yes 5 (21.7%)
  No 18 (78.3%)
Hypertension:
  Yes 10 (43.5%)
  No 13 (56.5%)
Taking donepezil or memantine:
  Yes 3 (13.1%)
  No 20 (86.9%)